您的位置: 首页 > 农业专利 > 详情页

Heterocykle zdolne do modulowania odpowiedzi limfocytów T, oraz sposoby ich stosowania
专利权人:
Nogra Pharma Limited
发明人:
HOMMES, DAAN,VERHAAR, Auke,VAN DEN BRINK, Gijs,VITI, FRANCESCA
申请号:
PL13726006
公开号:
PL2861575T3
申请日:
2013.05.31
申请国别(地区):
PL
年份:
2019
代理人:
摘要:
A data segment of a data packet destined for an egress port of an egress node may be received at a first ingress node. An egress statement vector and an ingress statement vector may be identified at the first ingress node. A determination may be made, based on the egress statement vector and ingress statement vector, whether the first ingress node is authorized to transfer the data segment to the egress port before the other data segments of the data packet are received at the first ingress node. The data segment may be transferred to the egress port before the other data segments of the data packet are received at the first ingress node when the determination indicates the first ingress node is authorized. The data segment may be stored in a buffer of the first ingress node when the determination indicates the first ingress node is not authorized.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充